Advertisement

epoch Ava puhi moni Anti-Dandruff Shampoo | Epoch

10:25 EDT 21st May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Drug Facts

Zinc Pyrithione 1%

Anti-dandruff

Controls the symptoms of dandruff.

For external use only

Water (Aqua), Ammonium Lauryl Sulfate, Ammonium Laureth Sulfate, Acrylates/Aminoacrylates/C10-30 Alkyl PEG-20 Itaconate Copolymer, Cocamide MEA, Cocamide MIPA, Dimethicone, Zingiber Zerumbet Juice, Clematis Vitalba Leaf Extract, Mahonia Aquifolium Root Extract, Salvia Officinalis (Sage) Leaf Extract, Urtica Dioica (Nettle) Extract, Panthenol, Butylene Glycol, Sodium Chloride, Citric Acid, Tetrasodium EDTA, Fragrance (Parfum), Methylchloroisothiazolinone, Methylisothiazolinone, Chlorophyllin-Copper Complex (CI 75810).

1-888-742-7626

epoch

Ava puhi moni

Anti-Dandruff Shampoo

the "true ava puhi"

250 ml e (8.4 fl. oz.)

IMAGE epoch-01.jpg

Manufacturer

NSE Products, Inc.

Active Ingredients

Source

Drugs and Medications [ 3 Associated Drugs and Medications listed on BioPortfolio]

Epoch [NSE Products, Inc.]

Epoch Acne Medication Blemish Treatment

Nu skin epoch [Alberto-Culver USA Inc.]

Epoch Antiseptic Hand Sanitizer

Epoch [NSE Products, Inc.]

Epoch® Antiseptic Hand Sanitizer

Clinical Trials [ 16 Associated Clinical Trials listed on BioPortfolio]

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

This is a randomized study of combination chemotherapy (EPOCH II) versus EPOCH II and immunotherapy with peripheral blood stem cells (PBSC) and IL-2 in patients with relapsed Hodgkin's and...

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

The prognosis of AIDS-related Non-Hodgkin's lymphoma is poor, especially in the relapsed setting. There is no standard treatment, and the few small studies that have been conducted have r...

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

No standard regimen currently exists for the treatment of AIDS-related lymphoma. Based on the encouraging NCI results with DA-EPOCH, the US AIDS Malignancy Consortium is currently administ...

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

5-Drug Combination Chemotherapy with Hematologic Toxicity Attenuation. EPOCH: Etoposide, VP-16, NSC-141540; Prednisone, PRED, NSC-10023; Vincristine, VCR, NSC-67574; Cyclophosphamide, CTX...

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

This study will evaluate the effectiveness of EPOCH-R chemotherapy plus bortezomib for treating mantle cell lymphoma, a cancer of white blood cells called lymphocytes. EPOCH-R consists of...

PubMed Articles [ 74 Associated PubMed Articles listed on BioPortfolio]

Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).

The Anthropocene: a new epoch of geological time?

Anthropogenic changes to the Earth's climate, land, oceans and biosphere are now so great and so rapid that the concept of a new geological epoch defined by the action of humans, the Anthropocene, is...

Fetal movement counting at home with a fetal movement acceleration measurement recorder: A preliminary report.

Abstract Objective: Fetal Movement Acceleration Measurement (FMAM) recorder was developed to facilitate gross fetal movement counting. The aim was to assess its reliability. Methods: Using the recorde...

EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT.

There exists a need for effective salvage regimens for multiple myeloma patients being considered for reduced-intensity allogeneic hematopoietic SCT (RI-alloHSCT). We developed EPOCH-F, a regimen cons...

Causes of death in infants admitted to australian neonatal intensive care units between 1995 and 2006.

AIM: To compare causes and rates of mortality among infants admitted to 10 Australian neonatal intensive care units (NICUs) between 1995 and 2006. METHODS: De-identified perinatal data from the Neonat...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement